Last 12 months
Inside the activity.
43 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 9 | 0 |
| Jun 2026 | 14 | 0 |
| Jul 2026 | 11 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 6 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2020 Filed Dec 18, 2020 06:08 UTC |
ADAMS ERIC ADirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043355 · ownership.xml · derivative · entry 1 ADAMS ERIC A · CIK 0001817882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common shares · 125,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 06:21 UTC |
MANCINI ALEXANDRA DIANE JANETSr VP, Clinical Reg Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043368 · ownership.xml · derivative · entry 1 MANCINI ALEXANDRA DIANE JANET · CIK 0001817890 · Sr VP, Clinical Reg Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common shares · 35,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 06:20 UTC |
HULL ANDREWDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043366 · ownership.xml · derivative · entry 1 HULL ANDREW · CIK 0001818252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common shares · 7,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 11:59 UTC |
WOUDENBERG MICHAELVP, Chem/Manufacturing/Control
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043408 · ownership.xml · derivative · entry 1 WOUDENBERG MICHAEL · CIK 0001817884 · VP, Chem/Manufacturing/Control 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common shares · 30,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 06:15 UTC | GrantEmployee Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043358 · ownership.xml · derivative · entry 1 COLWILL BRUCE · CIK 0001817743 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common shares · 60,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022. Read SEC document |
|
| December 16, 2020 Filed Dec 18, 2020 06:17 UTC |
Garner William JDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043362 · ownership.xml · derivative · entry 1 Garner William J · CIK 0001407235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common shares · 7,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 06:24 UTC |
Sazdanoff CatherineDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043371 · ownership.xml · derivative · entry 2 Sazdanoff Catherine · CIK 0001650901 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common shares · 11,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F3 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest monthly as follows: 325 vest on 01/16/2021; and 305 vest on the 16th day of each of the following 35 months. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 06:24 UTC |
Sazdanoff CatherineDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043371 · ownership.xml · derivative · entry 1 Sazdanoff Catherine · CIK 0001650901 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common shares · 7,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 06:16 UTC |
Cutler Adam D.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001213900-20-043360 · ownership.xml · derivative · entry 1 Cutler Adam D. · CIK 0001722673 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common shares · 7,000 shares Expires 2025-12-15 F1 · derivative.exercise_price: The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00. F2 · derivative.exercise_date: The options were granted on 12/16/2020 and will vest 100% on the one year anniversary of the grant date (Dec 16, 2021) or immediately prior to the next AGM, whichever is sooner. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.